Disease Outbreaks

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2021-02-23
EMA Withdrawn: Prepandrix (A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)) — GlaxoSmithKline Biologicals S.A.
The EMA indicates withdrawal of Prepandrix, an influenza vaccine, from the market.
EMA withdrawal · 2020-10-28
EMA Withdrawn: Vepacel (Influenza virus (whole virion, inactivated), containing antigen of: A/Vietnam/1203/2004 (H5N1)) — Ology Bioservices Ireland LTD
EMA withdrawn the Vepacel influenza vaccine (whole virion, inactivated; antigen A/Vietnam/1203/2004 H5N1) from Ology Bioservices Ireland Ltd…
EMA withdrawal · 2016-12-21
EMA Withdrawn: Celvapan (whole virion influenza vaccine, inactivated containing antigen of strain A/California/07/2009 (H1N1)v) — Nanotherapeutics Bohumil, s.r.o.
The EMA lists Celvapan as withdrawn from the market; it was a whole virion influenza vaccine against H1N1, with Nanotherapeutics Bohumil, s.…
EMA withdrawal · 2013-07-02
EMA Lapsed: Daronrix (whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs) — GlaxoSmithKline Biologicals S.A.
EMA indicates Daronrix has lapsed; a whole virion inactivated influenza vaccine against H5N1 produced in eggs by GlaxoSmithKline Biologicals…
EMA withdrawal · 2012-03-21
EMA Withdrawn: Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals (split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)) — GlaxoSmithKline Biologicals S.A.
The EMA withdrew Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) by GlaxoSmithKline Biologicals, a pre-pandemic…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
EMA withdrawal · 2011-06-30
EMA Withdrawn: Humenza (split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.) — Sanofi Pasteur S.A.
EMA has withdrawn the Humenza influenza vaccine from the market.